107 related articles for article (PubMed ID: 2271672)
1. Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity.
Walker F; Nice E; Fabri L; Moy FJ; Liu JF; Wu R; Scheraga HA; Burgess AW
Biochemistry; 1990 Nov; 29(47):10635-40. PubMed ID: 2271672
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor.
Richter A; Drummond DR; MacGarvie J; Puddicombe SM; Chamberlin SG; Davies DE
J Biol Chem; 1995 Jan; 270(4):1612-6. PubMed ID: 7829492
[TBL] [Abstract][Full Text] [Related]
3. Conformational characterization of a single-site mutant of murine epidermal growth factor (EGF) by 1H NMR provides evidence that leucine-47 is involved in the interactions with the EGF receptor.
Moy FJ; Scheraga HA; Liu JF; Wu R; Montelione GT
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9836-40. PubMed ID: 2690076
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor.
van de Poll ML; Lenferink AE; van Vugt MJ; Jacobs JJ; Janssen JW; Joldersma M; van Zoelen EJ
J Biol Chem; 1995 Sep; 270(38):22337-43. PubMed ID: 7673217
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors.
Defize LH; Boonstra J; Meisenhelder J; Kruijer W; Tertoolen LG; Tilly BC; Hunter T; van Bergen en Henegouwen PM; Moolenaar WH; de Laat SW
J Cell Biol; 1989 Nov; 109(5):2495-507. PubMed ID: 2553748
[TBL] [Abstract][Full Text] [Related]
6. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system.
Wiley HS
J Cell Biol; 1988 Aug; 107(2):801-10. PubMed ID: 3262110
[TBL] [Abstract][Full Text] [Related]
7. Effect of ErbB2 coexpression on the kinetic interactions of epidermal growth factor with its receptor in intact cells.
Wilkinson JC; Staros JV
Biochemistry; 2002 Jan; 41(1):8-14. PubMed ID: 11771997
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.
Felder S; LaVin J; Ullrich A; Schlessinger J
J Cell Biol; 1992 Apr; 117(1):203-12. PubMed ID: 1556153
[TBL] [Abstract][Full Text] [Related]
9. Real-time kinetics of ligand/cell surface receptor interactions in living cells: binding of epidermal growth factor to the epidermal growth factor receptor.
Wilkinson JC; Stein RA; Guyer CA; Beechem JM; Staros JV
Biochemistry; 2001 Aug; 40(34):10230-42. PubMed ID: 11513601
[TBL] [Abstract][Full Text] [Related]
10. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
[TBL] [Abstract][Full Text] [Related]
11. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.
Wharton W; Leof E; Pledger WJ; O'Keefe EJ
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052
[TBL] [Abstract][Full Text] [Related]
13. Structure-function studies of mEGF: probing the type I beta-turn between residues 25 and 26.
Lester CC; Wang B; Wu R; Scheraga HA
J Protein Chem; 1995 Nov; 14(8):753-62. PubMed ID: 8747437
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a bifunctionally spin-labeled mutant of murine epidermal growth factor for saturation-transfer electron paramagnetic resonance studies of the growth factor/receptor complex.
Rousseau DL; Guyer CA; Beth AH; Papayannopoulos IA; Wang B; Wu R; Mroczkowski B; Staros JV
Biochemistry; 1993 Aug; 32(31):7893-903. PubMed ID: 8394119
[TBL] [Abstract][Full Text] [Related]
15. Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality.
Mullenbach GT; Chiu CY; Gyenes A; Blaney J; Rosenberg S; Marlowe CK; Brown S; Stratton-Thomas J; Montelione GT; George-Nascimento C; Stauber G
Protein Eng; 1998 Jun; 11(6):473-80. PubMed ID: 9725626
[TBL] [Abstract][Full Text] [Related]
16. Binding of epidermal growth factor from man, rat and mouse to the human epidermal growth factor receptor.
Nexø E; Hansen HF
Biochim Biophys Acta; 1985 Nov; 843(1-2):101-6. PubMed ID: 2998475
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.
Prywes R; Livneh E; Ullrich A; Schlessinger J
EMBO J; 1986 Sep; 5(9):2179-90. PubMed ID: 3490969
[TBL] [Abstract][Full Text] [Related]
18. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity.
van de Poll ML; van Vugt MJ; Lenferink AE; van Zoelen EJ
Biochemistry; 1997 Jun; 36(24):7425-31. PubMed ID: 9200690
[TBL] [Abstract][Full Text] [Related]
19. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
Campion SR; Matsunami RK; Engler DA; Niyogi SK
Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
[TBL] [Abstract][Full Text] [Related]
20. Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.
Woltjer RL; Lukas TJ; Staros JV
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7801-5. PubMed ID: 1380167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
